{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T04:36:19Z","timestamp":1649046979525},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.semerg.2018.10.002","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T09:16:02Z","timestamp":1541409362000},"page":"e6-e7","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Elevaci\u00f3n de prolactina en personas con discapacidad intelectual con tratamiento psicofarmacol\u00f3gico"],"prefix":"10.1016","volume":"45","author":[{"given":"E.","family":"Gonz\u00e1lez-Pablos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"L\u00f3pez-Villalobos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Valles-de la Calle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Paulino-Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2018.10.002_bib0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/j.2051-5545.2009.tb00248.x","article-title":"International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities","volume":"8","author":"Deb","year":"2009","journal-title":"World Psychiatry"},{"key":"10.1016\/j.semerg.2018.10.002_bib0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.rpsm.2015.11.003","article-title":"Consenso espa\u00f1ol sobre los riesgos y detecci\u00f3n de la hiperprolactinemia iatrog\u00e9nica por antipsic\u00f3ticos","volume":"9","author":"Montejo","year":"2016","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"10.1016\/j.semerg.2018.10.002_bib0040","first-page":"265","article-title":"Disfunci\u00f3n sexual causada por medicamentos","volume":"24","author":"Nadal Llover","year":"2017","journal-title":"FMC."},{"key":"10.1016\/j.semerg.2018.10.002_bib0045","unstructured":"Organizaci\u00f3n Mundial de la Salud. Gu\u00eda de la clasificaci\u00f3n CIE-10. Madrid: Editorial M\u00e9dica Panamericana; 2000."},{"key":"10.1016\/j.semerg.2018.10.002_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semerg.2018.01.007","article-title":"La farmacovigilancia, nuestra aliada en la pr\u00e1ctica diaria","volume":"44","author":"Gonz\u00e1lez-Rubio","year":"2018","journal-title":"Semergen."}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359318303794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359318303794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T02:33:00Z","timestamp":1548556380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359318303794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1138359318303794"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2018.10.002","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevaci\u00f3n de prolactina en personas con discapacidad intelectual con tratamiento psicofarmacol\u00f3gico","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}